XML 61 R48.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Investment in LipoMedix Pharmaceuticals Ltd. (Details) - USD ($) |  |  |  | 1 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Nov. 15, 2021 | Nov. 11, 2021 | Sep. 01, 2021 | Mar. 31, 2021 | Jul. 31, 2022 | Nov. 30, 2021
Investment in LipoMedix Pharmaceuticals Ltd. (Details) [Line Items] |  |  |  |  |  |
Issued and outstanding ordinary shares, percentage |  |  |  |  | 84.00% |
Interest rate increase |  |  | 15.00% |  |  |
Ordinary shares (in Shares) | 15,975,000 |  |  |  |  |
Purchase price | $ 0.1878 |  |  |  |  |
Aggregate purchase price | $ 3,000,000 |  |  |  |  |
Noncontrolling interest |  |  |  |  | $ 8,000 |
Warrant [Member] |  |  |  |  |  |
Investment in LipoMedix Pharmaceuticals Ltd. (Details) [Line Items] |  |  |  |  |  |
Ordinary shares (in Shares) |  | 15,975,000 |  |  |  |
Purchase price |  | $ 0.1878 |  |  |  |
Maximum [Member] |  |  |  |  |  |
Investment in LipoMedix Pharmaceuticals Ltd. (Details) [Line Items] |  |  |  |  |  |
Percentage of noncontrolling interest |  |  |  |  | 84.00% |
Minimum [Member] |  |  |  |  |  |
Investment in LipoMedix Pharmaceuticals Ltd. (Details) [Line Items] |  |  |  |  |  |
Percentage of noncontrolling interest |  |  |  |  | 16.00% |
Lipomedix Pharmaceuticals Ltd. [Member] |  |  |  |  |  |
Investment in LipoMedix Pharmaceuticals Ltd. (Details) [Line Items] |  |  |  |  |  |
Maturity date |  |  |  | In March 2021, the Company provided bridge financing in the principal amount of up to $400,000 to LipoMedix with a maturity date of September 1, 2021, and an interest rate of 8% per annum. |  |
Principal amount |  |  |  | $ 400,000 |  |
Interest rate |  |  |  | 8.00% |  |
Ordinary shares (in Shares) |  |  |  |  | 15,975,000 |
Aggregate purchase price |  |  |  |  | $ 3,000,000 |
Principal amount outstanding |  |  |  |  |  | $ 400,000
Accrued interest |  |  |  |  |  | $ 21,800
Cash payment |  |  |  |  | $ 2,600,000 |

X
- Definition Accrued interest. + References No definition available. + Details
Name: | rfl_AccruedInterest
Namespace Prefix: | rfl_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of aggregate purchase price. + References No definition available. + Details
Name: | rfl_AmountOfAggregatePurchasePrice
Namespace Prefix: | rfl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash payment. + References No definition available. + Details
Name: | rfl_CashPayment
Namespace Prefix: | rfl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | rfl_InvestmentinLipoMedixPharmaceuticalsLtdDetailsLineItems
Namespace Prefix: | rfl_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | rfl_IssuedAndOutstandingOrdinarySharesPercentage
Namespace Prefix: | rfl_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Noncontrolling interest percentage. + References No definition available. + Details
Name: | rfl_NoncontrollingInterestPercentage
Namespace Prefix: | rfl_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | rfl_PurchasePrice
Namespace Prefix: | rfl_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The average effective interest rate during the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1F -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentInterestRateDuringPeriod
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Incremental percentage increase (decrease) in the stated rate on a debt instrument. + References No definition available. + Details
Name: | us-gaap_DebtInstrumentInterestRateIncreaseDecrease
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(2)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentMaturityDateDescription
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of the required periodic payments applied to principal. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentPeriodicPaymentPrincipal
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition This is the result of the principal amount outstanding of total loans managed or securitized less securitized loans and loans that are in the process of being securitized. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 860 -SubTopic 20 -Section 50 -Paragraph 4 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719 + Details
Name: | us-gaap_PrincipalAmountOutstandingOfLoansHeldInPortfolio
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 3A -Subparagraph (12)(c) -URI https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 3A -Subparagraph 15 -URI https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 3A -Subparagraph (16)(c) -URI https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Section S99 -Paragraph 3A -Subparagraph 14 -URI https://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764 + Details
Name: | us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644 + Details
Name: | us-gaap_SharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=rfl_LipomedixPharmaceuticalsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |